• Industry News
  • Law & Malpractice
  • Coding & Documentation
  • Practice Management
  • Finance
  • Technology
  • Patient Engagement & Communications
  • Billing & Collections
  • Staffing & Salary

Administering Overseas Drugs to Medicare Patients

Article

We are getting solicitations from companies who are selling products like Hyalgan and Boniva for less than 50 percent of the retail price in the United States. The meds are supposedly manufactured in the United States. Is purchasing medications from such companies and administering them to Medicare patients allowed?

Question: We are getting solicitations from companies who are selling products like Hyalgan and Boniva for less than 50 percent of the retail price in the United States. The meds are supposedly manufactured in the United States. Is purchasing medications from such companies and administering them to Medicare patients allowed?

Answer: There is a risk to you to selling patients drugs that the FDA has not approved (this includes all imported drugs). The Florida Board of Medicine and Florida Medical Association - as well as organizations in other states - are both against physician involvement in the importation of drugs.

Related Videos
The importance of vaccination
The fear of inflation and recession
Protecting your practice
Protecting your home, business while on vacation
Protecting your assets during the 100 deadly days
Payment issues on the horizon
The future of Medicare payments
MGMA comments on automation of prior authorizations
The burden of prior authorizations
Strategies for today's markets
© 2024 MJH Life Sciences

All rights reserved.